Compare ASMB & SLDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ASMB | SLDP |
|---|---|---|
| Founded | 2005 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electrical Products |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 512.1M | 552.2M |
| IPO Year | 2010 | 2021 |
| Metric | ASMB | SLDP |
|---|---|---|
| Price | $20.29 | $2.02 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 2 |
| Target Price | ★ $52.00 | $6.88 |
| AVG Volume (30 Days) | 202.1K | ★ 2.5M |
| Earning Date | 11-09-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 91.78 | 5.56 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $21,747,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $19.35 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 7.98 |
| 52 Week Low | $19.94 | $1.91 |
| 52 Week High | $39.71 | $8.86 |
| Indicator | ASMB | SLDP |
|---|---|---|
| Relative Strength Index (RSI) | 31.31 | 36.12 |
| Support Level | N/A | $1.98 |
| Resistance Level | $30.36 | $2.51 |
| Average True Range (ATR) | 1.10 | 0.11 |
| MACD | 0.10 | -0.03 |
| Stochastic Oscillator | 7.07 | 16.96 |
Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.
Solid Power Inc develops solid-state battery technology and manufacturing processes. Its sulfide-based solid electrolyte material replaces the liquid or gel electrolyte used in traditional lithium-ion battery cells and enables improvement in energy density, battery life and safety performance. The company produces electrolytes on two pilot manufacturing lines using a batch manufacturing process for customer sampling and internal cell development, and manufactures solid-state cells on pre-pilot and pilot cell manufacturing lines. Its cell manufacturing processes are developed around industry-standard lithium-ion battery manufacturing processes and equipment, and it manufactures all cell designs, including cathodes and anodes, using materials sourced from external suppliers.